drugset
drugset / Trial / NCT04214730

Study of NK Combined With Chemotherapy for Advanced Solid Tumor

NCT04214730 ↗

Unknown 60 enrolled Yantai Yuhuangding Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.

Timeline

Start
2019-12-31
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject NK Unknown — —

Indications

cancer